Clinical Scorecard: Psoriasis in Children: Associated Comorbidities, Treatment Obstacles, and Areas of Unmet Needs

At a Glance

Key Highlights

• Pediatric psoriasis is associated with obesity, cardiometabolic risks, and psychological disorders.
• Therapeutic options include pediatric-specific biologic therapies, but management remains challenging.
• Major unmet needs include delayed drug development and insufficient evaluation of extracutaneous outcomes.
• Early diagnosis and treatment are essential to minimize long-term consequences.
• Clinical decision-making often relies on adult data due to lack of pediatric-specific guidelines.

Guideline-Based Recommendations

Diagnosis

• Consider differential diagnoses such as eczema and fungal infections due to diagnostic complexity.

Management

• Utilize pediatric-specific biologic therapies where available and appropriate.

Monitoring & Follow-up

• Screen for associated comorbidities, including metabolic and psychiatric conditions.

Risks

• Be aware of access barriers, age restrictions, and off-label use of treatments.

Patient & Prescribing Data

Children and adolescents with psoriasis.

Limited long-term safety data for many systemic treatments.

Clinical Best Practices

• Implement integrated multidisciplinary strategies for optimal long-term outcomes.
• Conduct pediatric-focused research to address gaps in evidence.

Related Resources & Content

• Source Article